Saints Capital Granite, L.p. - Net Worth and Insider Trading
Saints Capital Granite, L.p. Net Worth
The estimated net worth of Saints Capital Granite, L.p. is at least $15 Million dollars as of 2024-11-13. Saints Capital Granite, L.p. is the 10% Owner of Enanta Pharmaceuticals Inc and owns about 1,425,708 shares of Enanta Pharmaceuticals Inc (ENTA) stock worth over $15 Million. Details can be seen in Saints Capital Granite, L.p.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Saints Capital Granite, L.p. has not made any transactions after 2013-10-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Saints Capital Granite, L.p.
Saints Capital Granite, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Saints Capital Granite, L.p. owns 1 companies in total, including Enanta Pharmaceuticals Inc (ENTA) .
Click here to see the complete history of Saints Capital Granite, L.p.’s form 4 insider trades.
Insider Ownership Summary of Saints Capital Granite, L.p.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ENTA | Enanta Pharmaceuticals Inc | 2013-10-14 | 10 percent owner |
Saints Capital Granite, L.p. Latest Holdings Summary
Saints Capital Granite, L.p. currently owns a total of 1 stock. Saints Capital Granite, L.p. owns 1,425,708 shares of Enanta Pharmaceuticals Inc (ENTA) as of October 14, 2013, with a value of $15 Million.
Latest Holdings of Saints Capital Granite, L.p.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ENTA | Enanta Pharmaceuticals Inc | 2013-10-14 | 1,425,708 | 10.66 | 15,198,047 |
Holding Weightings of Saints Capital Granite, L.p.
Saints Capital Granite, L.p. Form 4 Trading Tracker
According to the SEC Form 4 filings, Saints Capital Granite, L.p. has made a total of 0 transactions in Enanta Pharmaceuticals Inc (ENTA) over the past 5 years. The most-recent trade in Enanta Pharmaceuticals Inc is the sale of 32,301 shares on October 14, 2013, which brought Saints Capital Granite, L.p. around $640,852.
Insider Trading History of Saints Capital Granite, L.p.
- 1
Saints Capital Granite, L.p. Trading Performance
GuruFocus tracks the stock performance after each of Saints Capital Granite, L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Saints Capital Granite, L.p. is 6.5%. GuruFocus also compares Saints Capital Granite, L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Saints Capital Granite, L.p. within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Saints Capital Granite, L.p.'s insider trading performs compared to the benchmark.
Performance of Saints Capital Granite, L.p.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 20.66 | | | | | |
| Relative Return to S&P 500(%) | 19.48 | | | | | |
Saints Capital Granite, L.p. Ownership Network
Ownership Network List of Saints Capital Granite, L.p.
Ownership Network Relation of Saints Capital Granite, L.p.
Saints Capital Granite, L.p. Owned Company Details
What does Enanta Pharmaceuticals Inc do?
Who are the key executives at Enanta Pharmaceuticals Inc?
Saints Capital Granite, L.p. is the 10 percent owner of Enanta Pharmaceuticals Inc. Other key executives at Enanta Pharmaceuticals Inc include Chief Medical Officer Scott T. Rottinghaus , Sr. VP & New Product Dev. Tara Lynn Kieffer , and Sr. VP & Business Dev. Brendan Luu .
Enanta Pharmaceuticals Inc (ENTA) Insider Trades Summary
Over the past 18 months, Saints Capital Granite, L.p. made no insider transaction in Enanta Pharmaceuticals Inc (ENTA). Other recent insider transactions involving Enanta Pharmaceuticals Inc (ENTA) include a net sale of 12,479 shares made by Scott T. Rottinghaus , a net sale of 9,391 shares made by Tara Lynn Kieffer , and a net sale of 15,295 shares made by Terry Vance .
In summary, during the past 3 months, insiders sold 0 shares of Enanta Pharmaceuticals Inc (ENTA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 53,756 shares of Enanta Pharmaceuticals Inc (ENTA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 53,756 shares.
Enanta Pharmaceuticals Inc (ENTA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Enanta Pharmaceuticals Inc Insider Transactions
Saints Capital Granite, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Saints Capital Granite, L.p.. You might contact Saints Capital Granite, L.p. via mailing address: 475 Sansome Street, Suite 1850, San Francisco Ca 94111.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
